Mental Health

Tera Moore, PharmD, National Program Manager, VA Pharmacy Benefits Management office, explains the benefits of psychiatric pharmacist providers for patients and interprofessional practice.

Tera Moore, PharmD, discusses key strategies for successfully integrating psychiatric pharmacist providers in mental healthcare teams.

Tera Moore, National Program Manager with the VA Pharmacy Benefits Management Clinical Pharmacy Practice Office, discusses the role that psychiatric pharmacist providers play in their patients' mental health management.

Expanded mental health care at HIV clinics across the United States could help in reaching the goal of viral suppression among 90% of the population.

The new indication makes cariprazine the first and only dopamine and serotonin partial agonist to treat the full spectrum of bipolar I symptoms in manic, mixed, and depressive episodes.

Top news of the day from across the health care landscape.

A study in 2008 showed that approximately 5.2% of US adults age 18-80 years used benzodiazepines.

Using medications to induce calm is generally considered less desirable than other methods of de-escalation but is often necessary to prevent injury.

Mental Health First Aid, administered by the National Council for Behavioral Health, trains participants in mental health literacy, understanding risk factors and warning signs for mental health and addiction concerns and strategies for how to help someone in both crisis and non-crisis situations.

As highly accessible health care professionals, pharmacists have the opportunity to improve medication adherence and health outcomes of patients with bipolar disorder.

Building a rapport with your patients and supporting them is practically in the job description of a pharmacist. These abilities put pharmacists in a key position to intervene with people who may be contemplating suicide.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Although generic versions of prescription medications can be a cheaper alternative for patients, many perceive generics as less effective and less safe than their brand-name counterparts.

The prescription of stimulants for the treatment of attention deficit-hyperactivity disorder (ADHD) is increasing among adolescents and young adults, and a new study sheds light on possible safety concerns.

Suicide rates have risen in nearly every state since 1999.

In this clip, Taylor Watterson, a student at the University of Wisconsin-Madison School of Pharmacy, discusses the issue of pharmacists not recognizing when they are fatigued at work.

SSRIs have been shown to inhibit reuptake of serotonin in platelets, ultimately impairing platelet aggregation.

What landed this young man in critical condition, in the burn unit?

Once Spravato is determined as an appropriate treatment option, in accordance with the REMS, the patient will be treated at a certified treatment center that is trained to administer the medicine and address patient needs.

Flouxetine tablets were approved with the indication of treating multiple mental disorders.

The FDA has approved marketing of Lupin Pharmaceuticals’ Lurasidone Hydrochloride Tablets, a generic version of Sunovion Pharmaceuticals, Inc's lurasidone HCl (Latuda) tablets.

Top news of the day across the health care landscape.

How can pharmacists implement nonpharmacologic treatments for patients with dementia?

In this video, David Hager, PharmD, BCPS, the director of clinical pharmacy services at UW Health, Madison, WI, discusses the relationship between burnout and depression.

Stigma surrounding mental illnesses can prevent people from seeking treatment.